440 related articles for article (PubMed ID: 15075076)
1. Outcome of very late relapse in children with acute lymphoblastic leukemia.
Rizzari C; Valsecchi MG; Aricò M; Miniero R; Messina C; De Rossi G; Testi AM; Mura R; Galimberti S; Biondi A; Locatelli F; Conter V
Haematologica; 2004 Apr; 89(4):427-34. PubMed ID: 15075076
[TBL] [Abstract][Full Text] [Related]
2. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
[TBL] [Abstract][Full Text] [Related]
3. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.
Rivera GK; Zhou Y; Hancock ML; Gajjar A; Rubnitz J; Ribeiro RC; Sandlund JT; Hudson M; Relling M; Evans WE; Pui CH
Cancer; 2005 Jan; 103(2):368-76. PubMed ID: 15599932
[TBL] [Abstract][Full Text] [Related]
5. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group.
Borgmann A; Hartmann R; Schmid H; Klingebiel T; Ebell W; Göbel U; Peters C; Gadner H; Henze G
Bone Marrow Transplant; 1995 Apr; 15(4):515-21. PubMed ID: 7655375
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.
Einsiedel HG; von Stackelberg A; Hartmann R; Fengler R; Schrappe M; Janka-Schaub G; Mann G; Hählen K; Göbel U; Klingebiel T; Ludwig WD; Henze G
J Clin Oncol; 2005 Nov; 23(31):7942-50. PubMed ID: 16258094
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for relapsed childhood acute lymphoblastic leukemia: impact of allogeneic stem cell transplantation--a report from the Kyushu-Yamaguchi Children's Cancer Study Group.
Matsuzaki A; Nagatoshi Y; Inada H; Nakayama H; Yanai F; Ayukawa H; Kawakami K; Moritake H; Suminoe A; Okamura J
Pediatr Blood Cancer; 2005 Aug; 45(2):111-20. PubMed ID: 15782402
[TBL] [Abstract][Full Text] [Related]
9. Case-control analysis of allogeneic bone marrow transplantation versus maintenance chemotherapy for relapsed ALL in children.
Hoogerbrugge PM; Gerritsen EJ; vd Does-van den Berg A; vd Berg H; Zwinderman AH; Hermans J; Vossen JM
Bone Marrow Transplant; 1995 Feb; 15(2):255-9. PubMed ID: 7773215
[TBL] [Abstract][Full Text] [Related]
10. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukemia in third remission: a conceivable alternative?
Borgmann A; Baumgarten E; Schmid H; Dopfer R; Ebell W; Göbel U; Niethammer D; Gadner H; Henze G
Bone Marrow Transplant; 1997 Dec; 20(11):939-44. PubMed ID: 9422472
[TBL] [Abstract][Full Text] [Related]
12. Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia in remission: first choice for isolated extramedullary relapse?
Colleselli P; Rossetti F; Messina C; Rondelli R; Dini G; Meloni G; Miniero R; Andolina M; Locatelli F; Amici A
Bone Marrow Transplant; 1994 Nov; 14(5):821-5. PubMed ID: 7889016
[TBL] [Abstract][Full Text] [Related]
13. [Studies of children with acute lymphoblastic leukemia (ALL) who relapsed. Relationship of site of relapse, time and prognosis].
Shimizu H; Sasaki K; Takaue Y; Ota S; Fzjimoto T
Rinsho Ketsueki; 1989 Jul; 30(7):999-1004. PubMed ID: 2810802
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941.
Gaynon PS; Harris RE; Altman AJ; Bostrom BC; Breneman JC; Hawks R; Steele D; Zipf T; Stram DO; Villaluna D; Trigg ME
J Clin Oncol; 2006 Jul; 24(19):3150-6. PubMed ID: 16717292
[TBL] [Abstract][Full Text] [Related]
15. Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission.
Dini G; Valsecchi MG; Micalizzi C; Busca A; Balduzzi A; Arcese W; Cesaro S; Prete A; Rabusin M; Mazzolari E; Di Bartolomeo P; Sacchi N; Pession A; Giorgiani G; Lanino E; Lamparelli T; Favre C; Bosi A; Manzitti C; Galimberti S; Locatelli F
Bone Marrow Transplant; 2003 Aug; 32(3):325-31. PubMed ID: 12858206
[TBL] [Abstract][Full Text] [Related]
16. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic bone marrow transplantation in second remission of childhood acute lymphoblastic leukemia: a population-based case control study from the Nordic countries.
Schroeder H; Gustafsson G; Saarinen-Pihkala UM; Glomstein A; Jonmundsson G; Nysom K; Ringdén O; Mellander L
Bone Marrow Transplant; 1999 Mar; 23(6):555-60. PubMed ID: 10217185
[TBL] [Abstract][Full Text] [Related]
18. Anti-leukemic effect of graft-versus-host disease on bone marrow and extramedullary relapses in acute leukemia.
Lee JH; Choi SJ; Lee JH; Seol M; Lee YS; Ryu SG; Park CJ; Chi HS; Lee MS; Yun S; Lee JS; Lee KH
Haematologica; 2005 Oct; 90(10):1380-8. PubMed ID: 16219575
[TBL] [Abstract][Full Text] [Related]
19. Pathways through relapses and deaths of children with acute lymphoblastic leukemia: role of allogeneic stem-cell transplantation in Nordic data.
Saarinen-Pihkala UM; Heilmann C; Winiarski J; Glomstein A; Abrahamsson J; Arvidson J; Békássy AN; Forestier E; Jonmundsson G; Schroeder H; Vettenranta K; Wesenberg F; Gustafsson G
J Clin Oncol; 2006 Dec; 24(36):5750-62. PubMed ID: 17179109
[TBL] [Abstract][Full Text] [Related]
20. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
Kiehl MG; Kraut L; Schwerdtfeger R; Hertenstein B; Remberger M; Kroeger N; Stelljes M; Bornhaeuser M; Martin H; Scheid C; Ganser A; Zander AR; Kienast J; Ehninger G; Hoelzer D; Diehl V; Fauser AA; Ringden O
J Clin Oncol; 2004 Jul; 22(14):2816-25. PubMed ID: 15254049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]